Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TBAF-promoted dephenolative transcarbomylation: direct access to substituted carbamates & thiocarbamates.

Organic & biomolecular chemistry·2026
Same author

Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Non-infectious Uveitis.

Ophthalmology·2026
Same author

Strain-dependent bioactive-lipid interactions govern oxidative stability and antimicrobial functionality in Lentinula edodes.

Food research international (Ottawa, Ont.)·2026
Same author

Ubiquitin Ligases in pro-atrophic and antiatrophic signaling cascades in muscles.

Molecular biology reports·2026
Same author

Macromolecular Organization in Lentinula edodes: Integrating Co-Occurring Bioactives for Structure-Function Relationships Across Gut Microbiota and Host Metabolism.

Comprehensive reviews in food science and food safety·2026
Same author

Healing Without Wheat: Navigating the Nutritional Landscape of Gluten-Free Flours in Celiac Disease.

Nutrition reviews·2026

Related Experiment Video

Updated: Feb 19, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K

Checkpoint inhibitor-induced uveitis: a case series.

Christopher D Conrady1, Marissa Larochelle1, Paula Pecen2

  • 1Department of Ophthalmology, John A. Moran Eye Center, University of Utah, Salt Lake City, UT, 84112, USA.

Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie
|October 29, 2017
PubMed
Summary

Checkpoint inhibitors can cause autoimmune uveitis in patients with metastatic cancer. Prompt ophthalmologist evaluation is crucial for any new ocular complaints during treatment.

Keywords:
Autoimmune uveitisCheckpoint inhibitorsMetastatic cancer

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.2K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.9K

Related Experiment Videos

Last Updated: Feb 19, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.2K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.9K

Area of Science:

  • Oncology
  • Immunology
  • Ophthalmology

Background:

  • Checkpoint inhibitors are a standard treatment for metastatic cancer.
  • These therapies can modulate the immune system, potentially leading to autoimmune side effects.

Purpose of the Study:

  • To describe the clinical features and management of autoimmune non-infectious uveitis.
  • To investigate uveitis induced by checkpoint inhibitor drugs.

Main Methods:

  • A case series of seven patients with metastatic cancer treated with checkpoint inhibitors.
  • Patients were referred from uveitis practices at three tertiary centers.

Main Results:

  • All seven patients developed ocular inflammatory disease of varying severity.
  • The disease occurred while patients were undergoing checkpoint inhibitor therapy for metastatic cancer.

Conclusions:

  • Checkpoint inhibitors are associated with the induction of autoimmune uveitis.
  • Early ophthalmological evaluation is recommended for patients experiencing ocular complaints during checkpoint inhibitor therapy.